CompaniesTrophea Development

Trophea Development

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

1

As Collaborator

3

Total Enrollment

1,310

By Phase

PHASE2: 2PHASE2/PHASE3: 2

By Status

NOT_YET_RECRUITING: 3COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT06565507
Hover over trial bars to see details

Recent Trials

NCT06367361Collaborator
One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis
PHASE2Not yet recruiting
336 participants
Started: Aug 30, 2025 · Completed: Mar 1, 2028
NCT06565507Collaborator
Oxfendazole in Mild Parenchymal Brain Cysticercosis
PHASE2/PHASE3Not yet recruiting
544 participants
Started: Dec 15, 2024 · Completed: Dec 30, 2028
NCT03435718Lead Sponsor
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
PHASE2Not yet recruiting
250 participants
Started: Jul 31, 2024 · Completed: Oct 31, 2026
NCT00801203Collaborator
A Study to Evaluate the Effectiveness of the Induced Reflex Cough Test Plus Urodynamics to Identify Stress Urinary Incontinence in Female Subjects With a History of Stress Urinary Incontinence
PHASE2/PHASE3Completed
180 participants
Started: Dec 31, 2008 · Completed: Jul 31, 2009